Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
The Lancet. Respiratory Medicine
|
September 22, 2025
Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study
Shun Lu, Oleksandr Vynnychenko, Yaroslav Kulyaba, et al.
Cancer Science
|
March 20, 2026
Expression of Glycoprotein B (gB) Correlates With Poor Prognosis in Nasopharyngeal Carcinoma
Shigetaka Komura, Satoru Kondo, Hideya Kawasaki, et al.
BMC Infectious Diseases
|
April 7, 2021
Respiratory microbes detected in hospitalized adults with acute respiratory infections: associations between influenza A(H1N1)pdm09 virus and intensive care unit admission or fatal outcome in Vietnam (2015-2017)
Phuong Thai Truong, Shinji Saito, Ikuyo Takayama, et al.
Therapeutic Advances in Respiratory Disease
|
May 25, 2025
Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam
Van Luan Pham, Cam Phuong Pham, Thi Thai Hoa Nguyen, et al.
Asia-Pacific Journal of Clinical Oncology
|
December 18, 2024
The Effectiveness of Afatinib as First-Line Treatment in Vietnamese Patients With EGFR-Mutant Non-Small Cell Lung Cancer and Brain Metastases
Thai Van Pham, Thanh Ha Vu, Hoa Thai Thi Nguyen, et al.
Therapeutic Advances in Medical Oncology
|
May 13, 2024
Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam
Van Luan Pham, Tuan Anh Le, Cam Phuong Pham, et al.
BMC Cancer
|
February 5, 2024
A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam
Cam Phuong Pham, Thi Thai Hoa Nguyen, Anh Tu Do, et al.
Therapeutic Advances in Medical Oncology
|
October 21, 2025
Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam
Cam Phuong Pham, Hung Kien Do, Anh Tu Do, et al.
Plos One
|
November 18, 2025
Factors related to mortality in patients with acute respiratory distress syndrome (ARDS) in a lower middle-income country: A retrospective observational study
Co Xuan Dao, Chinh Quoc Luong, Toshie Manabe, et al.
Scientific Reports
|
March 3, 2025
Predictive validity of the sequential organ failure assessment score for mortality in patients with acute respiratory distress syndrome in Vietnam
Co Xuan Dao, Tuan Quoc Dang, Chinh Quoc Luong, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
The Lancet. Respiratory Medicine
|
September 22, 2025
Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised study
Shun Lu, Oleksandr Vynnychenko, Yaroslav Kulyaba, et al.
Cancer Science
|
March 20, 2026
Expression of Glycoprotein B (gB) Correlates With Poor Prognosis in Nasopharyngeal Carcinoma
Shigetaka Komura, Satoru Kondo, Hideya Kawasaki, et al.
BMC Infectious Diseases
|
April 7, 2021
Respiratory microbes detected in hospitalized adults with acute respiratory infections: associations between influenza A(H1N1)pdm09 virus and intensive care unit admission or fatal outcome in Vietnam (2015-2017)
Phuong Thai Truong, Shinji Saito, Ikuyo Takayama, et al.
Therapeutic Advances in Respiratory Disease
|
May 25, 2025
Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam
Van Luan Pham, Cam Phuong Pham, Thi Thai Hoa Nguyen, et al.
Asia-Pacific Journal of Clinical Oncology
|
December 18, 2024
The Effectiveness of Afatinib as First-Line Treatment in Vietnamese Patients With EGFR-Mutant Non-Small Cell Lung Cancer and Brain Metastases
Thai Van Pham, Thanh Ha Vu, Hoa Thai Thi Nguyen, et al.
Therapeutic Advances in Medical Oncology
|
May 13, 2024
Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam
Van Luan Pham, Tuan Anh Le, Cam Phuong Pham, et al.
BMC Cancer
|
February 5, 2024
A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam
Cam Phuong Pham, Thi Thai Hoa Nguyen, Anh Tu Do, et al.
Therapeutic Advances in Medical Oncology
|
October 21, 2025
Optimizing afatinib dosage: enhancing treatment outcomes and minimizing toxicities in advanced EGFR-mutated non-small cell lung cancer patients in Vietnam
Cam Phuong Pham, Hung Kien Do, Anh Tu Do, et al.
Plos One
|
November 18, 2025
Factors related to mortality in patients with acute respiratory distress syndrome (ARDS) in a lower middle-income country: A retrospective observational study
Co Xuan Dao, Chinh Quoc Luong, Toshie Manabe, et al.
Scientific Reports
|
March 3, 2025
Predictive validity of the sequential organ failure assessment score for mortality in patients with acute respiratory distress syndrome in Vietnam
Co Xuan Dao, Tuan Quoc Dang, Chinh Quoc Luong, et al.
Page
of 7